Page 7 - Sun Pharma

Top headlines: Sun Pharma's strong Q1 show, India-China military talks

Business Standard brings to you the top headlines on Saturday

Sun Pharma: Strong Q1 show, settlement of antitrust case pleases investors

Lack of pricing pressure, especially in the US, and debt reduction are other positives

Q1 results: Sun Pharma in the black, posts Rs 1,444-crore profit

Revenue from operations in the first quarter rose 29 per cent year-on-year and 14 per cent on a sequential basis to Rs 9,669 crore

Top headlines: Sun Pharma posts profit in Q1; Bandhan Bank Q1 net falls 32%

Business Standard brings you the top headlines on Friday

Sun Pharma posts consolidated net profit of Rs 1,444 crore in Q1

The company had posted a net loss of Rs 1,655.60 crore for the corresponding period of the previous fiscal

Sun Pharma rallies 9%, hits over 4-year high on strong June quarter results

The management said Sun Pharma witnessed a strong Q1, driven by a combination of robust core business growth, low base and some sale of Covid products

NPPA allows 50% price hike for ibuprofen, ranitidine, carbamazepine

These are scheduled drugs (or ones that are under price control) and low priced

Cipla, Dr Reddy's Labs: Tech charts show up to 11% upside in pharma stocks

After hitting a new all-time high of Rs 997 earlier today, the stock of Cipla is all set to rally towards Rs 1,100

Stock ideas by Ajit Mishra of Religare Broking: Buy Info Edge, Sun Pharma

IGL has witnessed a breakout from the consolidation range of Rs 500-545 levels after spending nearly four months there

Suraksha group may have to cross legal hurdles to take control of Jaypee

With Jaypee in its kitty, Suraksha will get highly visible assets such as the Noida-Agra Expressway and the land bank around the expressway, and 730-bed hospitals in Noida and Bulandshahr

Sun Pharma settles patent dispute with US-based Celgene Corporation

Pharma major Sun Pharmaceutical Industries Ltd. on Tuesday said it along with one of its subsidiaries have reached an agreement with Celgene Corporation (Celgene) to resolve a patent litigation.

No plans to make vaccine as it requires separate infra: Sun Pharma

Sun Pharma has no immediate plans to enter into vaccine production as getting into the vertical would require an altogether different manufacturing set-up, as per a top company official.

Sun Pharma, Ferring Pharma ink pact to introduce obstetric drug in India

The drug is indicated for the prevention of excessive bleeding in women after vaginal or caesarean childbirth

Sun Pharma dips 3% on profit booking post March quarter results

In the past three months, the stock outperformed the market by gaining nearly 20 per cent, as compared to 4.6 per cent rise in the S&P BSE Sensex, till Thursday

Sun Pharma Q4 net more than doubles to Rs 894 cr on better operational show

Low base supported overall performance; consolidated sales from operations came in at Rs 8,431 crore, up 4.4% YoY

Top headlines: Sun Pharma Q4 net rises two-fold; govt hits back at Twitter

Nifty holds 15,300, sees all-time closing high, RBI flags risk of bubble in Indian equity markets and other top news of the day

Sun Pharma Q4 net more than doubles to Rs 894 cr; declares dividend of Rs 2

Its revenue from operations came in at Rs 8,522 crore for the quarter under review, an increase of 4 per cent from the previous year

Stocks to watch: BPCL, Burger King, Eicher Motors, Sun Pharma, Pfizer

BPCL's board has approved a final dividend of Rs 58 per share, which includes a one-time special dividend of Rs 35 per equity share

Sun Pharma recalls 50,868 bottles of diabetes drug Metformin HCl in US

Drug major Sun Pharma is recalling 50,868 bottles of diabetes drug Metformin HCl extended-release tablets in the US market, according to the US Food and Drug Administration (USFDA).

Nifty Pharma index hits all-time high; Sun Pharma scales 4-year high

Since April, the index has outperformed the market by surging 15 per cent, against 1.7 per cent gain in the Nifty50; Sun Pharma scales 4-year high